Valls, Laia <br/><br/>
Early response monitoring of receptor tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma using [F-18]fluorothymidine-positron emission tomography-magnetic resonance.  [electronic resource] 

 -  Seminars in roentgenology  Jul 2014 
 - 238-41 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1558-4658 
<br/><br/><label>Standard No.: </label>10.1053/j.ro.2014.09.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Renal Cell--diagnosis<br/>Contrast Media<br/>Diffusion Magnetic Resonance Imaging<br/>Gadolinium DTPA<br/>Humans<br/>Image Enhancement<br/>Indoles--therapeutic use<br/>Kidney Neoplasms--diagnosis<br/>Magnetic Resonance Spectroscopy<br/>Male<br/>Middle Aged<br/>Multimodal Imaging<br/>Positron-Emission Tomography<br/>Protein Kinase Inhibitors--therapeutic use<br/>Pyrroles--therapeutic use<br/>Radiopharmaceuticals<br/>Sunitinib<br/>Tomography, X-Ray Computed<br/>Treatment Outcome<br/>Tyrosine--analogs & derivatives